Daniel M. Hutcheson, '12, (AXP-11)

Chief Operating Officer, Neuroscience Research Unit, Pfizer, Inc.

Originally from England, in 2012 Hutcheson moved to the US to join the leadership of Pfizer Neuroscience research unit, taking the post of chief operating officer. He was responsible for all business and laboratory operations. He also managed a discovery operations group of experienced project managers covering high-profile portfolio assets in pre-clinical and clinical phases.

Prior to Pfizer, Hutcheson worked at Maccine, Ltd., as director of discovery research. Under his leadership the discovery group tripled in size and generated the company highest revenue contribution for three consecutive years. Before Maccine, Hutcheson was a senior scientist at GlaxoSmithKline, and he received a GSK Excellence in Science Award in 2005 and a GSK Animal Welfare Award in 2006.

In 2012 Hutcheson earned his executive MBA from the University of Chicago Booth School of Business. He earned a bachelor’s degree in pharmacology & toxicology, and attained a PhD through research in psychopharmacology at Cardiff University. Following postdoctoral research in Paris (INSERM), he was awarded a Medical Research Council Training Fellowship at the University of Cambridge and was elected a Research Fellow of Hughes Hall College.